Clinical trials of genome-editing agents — including CRISPR–Cas9 editors, zinc finger nucleases and TALENs — are pushing ex vivo, immuno-oncology and in vivo treatment frontiers.
Focus
CRISPR
Client
UC Berkeley
READ THE ...
China has used the genome editor more aggressively, on more species, than any other country.
Early one February morning, researchers harvest six eggs from a female rhesus macaque—one of 4000 ...
Top CRISPR researchers at two University of California (UC) campuses have teamed up with pharmaceutical giant GlaxoSmithKline (GSK) to form a new laboratory in San Francisco that will exploit the ...
To minimize the off-target effects of CRISPR-based genome editing, researchers have designed a version of Cas9, the enzyme that cuts DNA, that avoids mistakes with unprecedented precision. Mutating one ...
